Equity Overview
Price & Market Data
Price: $25.17
Daily Change: -$1.47 / 5.84%
Daily Range: $22.51 - $28.10
Market Cap: $1,886,246,308
Daily Volume: 221,397
Performance Metrics
1 Week: -11.71%
1 Month: -37.98%
3 Months: -60.70%
6 Months: 65.40%
1 Year: 65.40%
YTD: 65.40%
Company Details
Employees: 29
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Jyong Biotech Ltd., a science-driven biotechnology company, develops and commercializes plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops MCS-2 for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.